Juan Luis García‐Rivero

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample

Manuel Gurpegui, José M. Martínez-Ortega, Luís Gutiérrez-Rojas et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2012 · 74 citations

Obesity, Psychiatry, Psychotic Disorder +8

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease

Miguel Santibáñez, Roberto Garrastazu, Mario Ruiz-Nuñez et al. · PLoS ONE · 2016 · 56 citations · Full text

The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations

Patricia García-Sidro, Elsa Naval, Carlos Martínez‐Rivera et al. · Respiratory Medicine · 2015 · 49 citations · Full text

Epidemiology, Advanced Lung Disease, Diagnosis +5

Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations

Carlos Martínez‐Rivera, Astrid Crespo‐Lessmann, Celia Pinedo-Sierra et al. · Respiratory Medicine · 2018 · 48 citations · Full text

Asthma, Allergy, Inflammatory Lung Disease +6